Plenary session

Watch the program
10:00 - 12:00

Opening of the Conference
Plenary session

Strong regulator – robust industry

Questions and topics for discussion:
• Structural approach in bringing the Russian industry to an international level
• Actions of the regulatory authorities during the pandemic.
• Experience of inter-agency interaction.
• Analysis of decisions made and their results
• Experience of foreign drug regulatory authorities


Vladislav Shestakov

Vladislav Shestakov

Director of the FSI "State Institute of Drugs and Good Practices", Russian Ministry of Industry and Trade

*Dmitry Galkin

*Dmitry Galkin

Director of the Department of Pharmaceutical and Medical Industry Development, Ministry of Industry and Trade of the Russian Federation


Kirill Soloveichik

Head of the Committee for Industrial Policy, Innovations and Trade of Saint Petersburg

Ekaterina Nikifirova

Fillip Romanov

Director of Department for State Regulation of Drug Circulation of the Ministry of Health of the Russian Federation

Elena Kudryavtseva

Head of the Directorate for Organization of State Control of Medicinal Products, Federal Service for Surveillance in Healthcare

Ekaterina Nikifirova

Dzhanyl Dzhusupova

Director of the Technical Regulation and Accreditation Department of the Eurasian Economic Commission

Timurlan Kуsanov

Director of the Department of drugs and medical devices of the Ministry of Health of Republic of Kazakhstan

Ekaterina Nikifirova

Jérôme Lepeintre

Minister - Counsellor for health and agriculture of the EU Delegation to the Russian Federation

Ekaterina Nikifirova

Michel Sidibé

African Union's Special Envoy for the African Medicines Agency

Ekaterina Nikifirova

Olga Lidia Jacobo Casanueva

Director of Center for State Control of Medicines and Medical Devices (Cuba)

Ekaterina Nikifirova

Muhammed Mahbubur Rahman

Director General of Directorate General of Drug Administration (Bangladesh)

Ekaterina Nikifirova

Leandro Villanueva

General Director of the General Directorate of Medicines, Food and Health Products of Ministry of Public Health of the Dominican Republic

Neale Baldwin

Senior GMP inspector of Therapeutic Goods Administration (Australia)

Ekaterina Nikifirova

Kamel Mansouri

General Director of National Agency of Pharmaceutical Products (Algeria)

Session content